基于核磁共振的代谢组学与CKD风险
英国生物银行91,532名无CKD且未接受降脂治疗的参与者中,中位随访13.1年发生2,269例CKD。142个生物标志物中90个与CKD发病显著相关;VLDL颗粒浓度较高与CKD风险升高相关,HDL颗粒浓度较高与风险降低相关。
要点
- VLDL颗粒浓度较高与CKD风险升高相关,HDL颗粒浓度较高与风险降低相关。
- VLDL内胆固醇、磷脂和总脂较高与CKD风险升高相关,HDL内则与风险降低相关。
- 所有脂蛋白亚类(包括所有HDL颗粒)内甘油三酯较高均与CKD风险升高相关。
核心结论
- 研究发现多个已知和新型通路将循环代谢物与CKD风险联系起来。
研究设计与样本
- 观察性队列研究,纳入英国生物银行91,532名无CKD且未接受降脂治疗的参与者,通过核磁共振波谱定量代谢物,中位随访13.1年。
主要发现
- 随访期间通过电子健康记录 linkage 识别2,269例CKD病例。
- 校正协变量并多重检验校正后,142个生物标志物中90个与CKD发病显著相关。
- VLDL颗粒浓度较高与CKD风险升高相关,HDL颗粒浓度较高与CKD风险降低相关。
- VLDL内胆固醇、磷脂和总脂较高与CKD风险升高相关,HDL内则与风险降低相关。
- 所有脂蛋白亚类(包括所有HDL颗粒)内甘油三酯较高与CKD风险升高相关;部分氨基酸、脂肪酸和炎症标志物亦与CKD风险相关。
关键数值与推荐
- 142个生物标志物中90个与CKD发病显著相关(校正协变量及多重检验后)。
临床怎么用
- 原文未报告临床实践建议。
局限性
- 因通过电子健康记录识别病例,CKD病例可能存在漏报。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Chronic kidney disease (CKD) leads to lipid and metabolic abnormalities, but a comprehensive investigation of lipids, lipoprotein particles, and circulating metabolites associated with the risk of CKD has been lacking. We examined the associations of nuclear magnetic resonance (NMR)-based metabolomics data with CKD risk in the UK Biobank study. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: A total of 91,532 participants in the UK Biobank Study without CKD and not receiving lipid-lowering therapy. EXPOSURE: Levels of metabolites including lipid concentration and composition within 14 lipoprotein subclasses, as well as other metabolic biomarkers were quantified via NMR spectroscopy. OUTCOME: Incident CKD identified using ICD codes in any primary care data, hospital admission records, or death register records. ANALYTICAL APPROACH: Cox proportional hazards regression models were used to estimate hazard ratios and 95% confidence intervals. RESULTS: We identified 2,269 CKD cases over a median follow-up period of 13.1 years via linkage with the electronic health records. After adjusting for covariates and correcting for multiple testing, 90 of 142 biomarkers were significantly associated with incident CKD. In general, higher concentrations of very-low-density lipoprotein (VLDL) particles were associated with a higher risk of CKD whereas higher concentrations of high-density lipoprotein (HDL) particles were associated with a lower risk of CKD. Higher concentrations of cholesterol, phospholipids, and total lipids within VLDL were associated with a higher risk of CKD, whereas within HDL they were associated with a lower risk of CKD. Further, higher triglyceride levels within all lipoprotein subclasses, including all HDL particles, were associated with greater risk of CKD. We also identified that several amino acids, fatty acids, and inflammatory biomarkers were associated with risk of CKD. LIMITATIONS: Potential underreporting of CKD cases because of case identification via electronic health records. CONCLUSIONS: Our findings highlight multiple known and novel pathways linking circulating metabolites to the risk of CKD. PLAIN-LANGUAGE SUMMARY: The relationship between individual lipoprotein particle subclasses and lipid-related traits and risk of chronic kidney disease (CKD) in general population is unclear. Using data from 91,532 participants in the UK Biobank, we evaluated the associations of metabolites measured using nuclear magnetic resonance testing with the risk of CKD. We identified that 90 out of 142 lipid biomarkers were significantly associated with incident CKD. We found that very-low-density lipoproteins, high-density lipoproteins, the lipid concentration and composition within these lipoproteins, triglycerides within all the lipoprotein subclasses, fatty acids, amino acids, and inflammation biomarkers were associated with CKD risk. These findings advance our knowledge about mechanistic pathways that may contribute to the development of CKD.
引用
- Geng TT, Chen JX, Lu Q, et al. Nuclear Magnetic Resonance-Based Metabolomics and Risk of CKD. Am J Kidney Dis. 2023. PMID: 37678743. doi:10.1053/j.ajkd.2023.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。